A Multicenter Randomized Phase III Study of Combination Treatment With Vinorelbine and Gemcitabine Versus Capecitabine Monotherapy in Metastatic Breast Cancer Patients Following Treatment Failure With the Combination of a Taxane and an Anthracycline
This trial will compare the efficacy of combination treatment with Vinorelbine and
Gemcitabine versus Capecitabine monotherapy in metastatic breast cancer patients following
treatment failure with the combination of a taxane and an anthracycline.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Time to tumor progression between the two treatment arms
1 year
No
Dimitris Mavrudis, MD
Principal Investigator
University Hospital of Crete
Greece: National Organization of Medicines
CT/02.11
NCT00431106
April 2002
January 2009
Name | Location |
---|